Imaging the effects of propofol on human cerebral glucose metabolism using positron emission tomography

Journal of International Medical Research

Volumn 36, Issue 6, 2008, Pages 1305-1310

  Sun, Xude ^a   Zhang, H ^b   Gao, C ^a   Zhang, G ^a   Xu, L ^b   Lv, M ^a   Chai, W ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brain metabolism; Glucose; Positron emission tomography (PET); Propofol

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; PROPOFOL; DIAGNOSTIC AGENT; INTRAVENOUS ANESTHETIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG SENSITIVITY; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; SEDATION; THALAMUS; UNCONSCIOUSNESS; VOLUNTEER; WAKEFULNESS; BRAIN; BRAIN MAPPING; DRUG EFFECT; METABOLISM; METHODOLOGY; SCINTISCANNING;

ADULT; ANESTHETICS, INTRAVENOUS; BRAIN; BRAIN MAPPING; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROPOFOL; RADIOPHARMACEUTICALS;

EID: 59649098500     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600618     Document Type: Article

References (16)

1. Ziegler SI: Positron emission tomography: Principles, technology, and recent developments. Nuclear Physics A 2005; 752: 679-687.
2. Akcali C, Zincirkeser S, Erbagcy Z, et al: Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT. J Int Med Res 2007; 35: 547-553.
3. 11C]PK-11195 and animal PET following ethanol injury in rat striatum. Ann Nucl Med 2008; 22: 417-424.
4. Tipre DN, Fox JJ, Holt DP, et al: In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat. J Nucl Med 2008; 49: 1189-1195.
5. Helms LB, Thompson ES: Nurse anesthesia students with disabilities: a legal and academic review of potential professional standards. AANA J 2005; 73: 265-269.
6. Dawson N, Ferrington L, Olverman HJ, et al: Novel analysis for improved validity in semi-quantitative 2-deoxyglucose autoradiographic imaging. J Neurosci Methods 2008; 175: 25-35.
7. Jeong YB, Kim JS, Jeong SM, et al: Comparison of the effects of sevoflurane and propofol anaesthesia on regional cerebral glucose metabolism in humans using positron emissiom tomography. J Int Med Res 2006; 34: 374-384.
8. 11C-methyl]-benztropine and application to studies of propofol-induced unconsciousness in healthy human volunteers. Synapse 2004; 51: 91-101.
9. Aine CJ: A conceptual overview and critique of functional neuroimaging technigues in humans: MRI/FMRI and PET. Crit Rev Neurobiol 1995; 9: 229-309.
10. Raichle M: Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci USA 1998; 95: 765-772.
11. Laalou FZ, de Vasconcelos AP, Oberling P, et al: Involvement of the basal cholinergic forebrain in the mediation of general (propofol) anesthesia. Anesthesiology 2008; 108: 888-896.
12. Frank NP, Lieb WR: Molecular and cellular mechanisms of general anesthesia. Nature 1994; 367: 607-614.
13. A receptor with the intravenous agent, propofol. Eur J Pharmacol 2008; 590: 120-126.
14. A receptor desensitization. Toxicol Lett 1998; 100: 217-224.
15. Juengling FD, Kassubek J, Martens-Le Bouar HM, et al: Cerebral regional hypometabolism caused by propofol induced sedation in children with severe myoclonic epilepsy: a study using fluorodeoxyglucose positron emission tomography and statistical parametric mapping. Neurosci Lett 2002; 335: 79-82.
16. Sperti C, Pasquali C, Decet G, et al: F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg 2005; 9: 22-29.